@prajishiyer.bsky.social
Reposted
ICYMI: Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia?
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
September 14, 2025 at 12:10 PM
ICYMI: Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia?
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
Reposted
Proud of you, Prajish!
Thank you @iwCLL2025 for the opportunity to present in Poland @wanglabcityofhope.bsky.social @ericalytical.bsky.social
September 14, 2025 at 2:45 PM
Proud of you, Prajish!
Thank you @iwCLL2025 for the opportunity to present in Poland @wanglabcityofhope.bsky.social @ericalytical.bsky.social
September 14, 2025 at 2:04 PM
Thank you @iwCLL2025 for the opportunity to present in Poland @wanglabcityofhope.bsky.social @ericalytical.bsky.social
Reposted
Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia?
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
September 10, 2025 at 2:13 PM
Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia?
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
@prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B
Reposted
Congratulations to my graduate student, Erica Niewold @ericalytical.bsky.social, for being selected by @ash.hematology.org to receive the ASH Graduate Hematology Award (AGHA)! #ASHAwards
May 31, 2025 at 4:09 PM
Congratulations to my graduate student, Erica Niewold @ericalytical.bsky.social, for being selected by @ash.hematology.org to receive the ASH Graduate Hematology Award (AGHA)! #ASHAwards
Reposted
Very proud of my trainee Prajish @prajishiyer.bsky.social receiving Career Development Grant from Tower Cancer Research Foundation! Congratulations, Prajish!
January 10, 2025 at 5:45 AM
Very proud of my trainee Prajish @prajishiyer.bsky.social receiving Career Development Grant from Tower Cancer Research Foundation! Congratulations, Prajish!
Thank you Tower Cancer research foundation for the early career investigator award. @wanglabcityofhope.bsky.social
December 27, 2024 at 4:33 PM
Thank you Tower Cancer research foundation for the early career investigator award. @wanglabcityofhope.bsky.social
Thank you #ASH2024 for the opportunity to share our research on Richters transformation @ash-hematology.bsky.social @wanglabcityofhope.bsky.social
December 10, 2024 at 7:32 PM
Thank you #ASH2024 for the opportunity to share our research on Richters transformation @ash-hematology.bsky.social @wanglabcityofhope.bsky.social